X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3058) 3058
Publication (300) 300
Book Review (44) 44
Newsletter (14) 14
Book / eBook (8) 8
Magazine Article (5) 5
Book Chapter (4) 4
Newspaper Article (4) 4
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2326) 2326
tobramycin - therapeutic use (1342) 1342
male (1204) 1204
tobramycin (1159) 1159
female (1155) 1155
anti-bacterial agents - therapeutic use (986) 986
adult (861) 861
index medicus (854) 854
tobramycin - administration & dosage (726) 726
middle aged (712) 712
pharmacology & pharmacy (642) 642
anti-bacterial agents - administration & dosage (640) 640
antibiotics (551) 551
aged (545) 545
pseudomonas infections - drug therapy (539) 539
cystic fibrosis (521) 521
adolescent (487) 487
animals (422) 422
drug therapy, combination (395) 395
child (390) 390
microbial sensitivity tests (376) 376
microbiology (364) 364
pseudomonas aeruginosa (351) 351
pseudomonas aeruginosa - drug effects (344) 344
anti-bacterial agents - pharmacology (342) 342
respiratory system (330) 330
tobramycin - pharmacology (327) 327
bacterial infections - drug therapy (314) 314
gentamicin (313) 313
cystic fibrosis - complications (294) 294
treatment outcome (293) 293
administration, inhalation (281) 281
infectious diseases (274) 274
prospective studies (272) 272
cystic fibrosis - drug therapy (270) 270
infections (267) 267
aminoglycosides (261) 261
tobramycin - adverse effects (257) 257
anti-bacterial agents - pharmacokinetics (244) 244
gentamicins - therapeutic use (244) 244
pseudomonas-aeruginosa (224) 224
anti-bacterial agents - adverse effects (222) 222
infection (222) 222
pharmacokinetics (220) 220
child, preschool (207) 207
therapy (207) 207
cystic-fibrosis (205) 205
ophthalmology (189) 189
tobramycin - pharmacokinetics (189) 189
time factors (186) 186
pediatrics (179) 179
aged, 80 and over (177) 177
drug therapy, combination - therapeutic use (173) 173
cystic fibrosis - microbiology (169) 169
bacteria (163) 163
children (161) 161
drug resistance, microbial (160) 160
retrospective studies (160) 160
tobramycin - blood (159) 159
drug administration schedule (158) 158
health aspects (157) 157
pseudomonas infections - microbiology (157) 157
surgery (152) 152
efficacy (148) 148
infant (145) 145
clinical trials as topic (144) 144
inhaled tobramycin (142) 142
ciprofloxacin (141) 141
resistance (140) 140
drug therapy (137) 137
analysis (134) 134
research article (134) 134
pseudomonas aeruginosa - isolation & purification (131) 131
respiratory tract infections - drug therapy (129) 129
care and treatment (127) 127
gentamicins - administration & dosage (123) 123
amikacin (122) 122
double-blind method (122) 122
aerosols (119) 119
pseudomonas infections - complications (119) 119
drug delivery systems (118) 118
medicine, general & internal (118) 118
gentamicins - pharmacology (117) 117
rabbits (117) 117
amikacin - therapeutic use (116) 116
young adult (116) 116
biofilms (115) 115
dose-response relationship, drug (114) 114
antibacterial agents (111) 111
staphylococcal infections - drug therapy (110) 110
anti-bacterial agents - blood (109) 109
cephalosporins - therapeutic use (109) 109
rats (109) 109
inhalation (108) 108
ciprofloxacin - therapeutic use (107) 107
random allocation (104) 104
drug combinations (102) 102
management (102) 102
research (101) 101
nebulizers and vaporizers (100) 100
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2824) 2824
French (60) 60
German (54) 54
Spanish (37) 37
Italian (33) 33
Russian (24) 24
Japanese (23) 23
Hungarian (6) 6
Polish (6) 6
Chinese (5) 5
Czech (3) 3
Hebrew (3) 3
Portuguese (3) 3
Romanian (3) 3
Croatian (2) 2
Danish (2) 2
Dutch (2) 2
Norwegian (2) 2
Bulgarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 2011, Volume 12, Issue 3, pp. 157 - 169
Journal Article
Journal Article
Journal Article
European Respiratory Journal, ISSN 0903-1936, 09/2017, Volume 50, Issue 3, pp. 1700629 - 1700629
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 01/2015, Volume 198, pp. 55 - 61
Inhaled antibiotics, such as tobramycin, for the treatment of pulmonary infections are associated with the increase in life expectancy seen in cystic fibrosis... 
Pseudomonas aeruginosa | Alginate | DNase | Tobramycin | Nanoparticle | Cystic fibrosis sputum | CHITOSAN/ALGINATE NANOPARTICLES | VIVO | DRUG-DELIVERY | SPUTUM | LUNG INFECTION | CHEMISTRY, MULTIDISCIPLINARY | BACTERIAL BIOFILMS | DEXTRAN SULFATE | IN-VITRO CHARACTERIZATION | GALLERIA-MELLONELLA | OCULAR DELIVERY | PHARMACOLOGY & PHARMACY | Recombinant Proteins - therapeutic use | Nanoparticles - chemistry | Humans | Pseudomonas aeruginosa - growth & development | Tobramycin - pharmacology | Deoxyribonuclease I - therapeutic use | Tobramycin - administration & dosage | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Deoxyribonuclease I - chemistry | Deoxyribonuclease I - pharmacology | Nanoparticles - therapeutic use | Anti-Bacterial Agents - chemistry | Adult | Tobramycin - chemistry | Glucuronic Acid - chemistry | Tobramycin - therapeutic use | Pseudomonas Infections - drug therapy | Recombinant Proteins - chemistry | Treatment Outcome | DNA - metabolism | Hexuronic Acids - chemistry | Pseudomonas aeruginosa - drug effects | Recombinant Proteins - pharmacology | Deoxyribonuclease I - administration & dosage | Chemistry, Pharmaceutical | Recombinant Proteins - administration & dosage | Sputum - metabolism | Chitosan - chemistry | Alginates - chemistry | Anti-Bacterial Agents - pharmacology | Nanoparticles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Dornase alfa | Analysis | Cystic fibrosis | Polymers | Health aspects | Index Medicus
Journal Article